174 related articles for article (PubMed ID: 9457719)
1. Medulloblastoma: survival and late recurrence after the Collins' risk period.
Nishio S; Morioka T; Takeshita I; Fukui M
Neurosurg Rev; 1997; 20(4):245-9. PubMed ID: 9457719
[TBL] [Abstract][Full Text] [Related]
2. Collins' law. Prediction of recurrence or cure in childhood medulloblastoma?
Sure U; Berghorn WJ; Bertalanffy H
Clin Neurol Neurosurg; 1997 May; 99(2):113-6. PubMed ID: 9213055
[TBL] [Abstract][Full Text] [Related]
3. Medulloblastoma. Period of risk reviewed.
Latchaw JP; Hahn JF; Moylan DJ; Humphries R; Mealey J
Cancer; 1985 Jan; 55(1):186-9. PubMed ID: 3965079
[TBL] [Abstract][Full Text] [Related]
4. Recurrence of medulloblastoma: violation of Collins' law after two decades.
Friedberg MH; David O; Adelman LS; Heilman CB
Surg Neurol; 1997 Jun; 47(6):571-4. PubMed ID: 9167782
[TBL] [Abstract][Full Text] [Related]
5. Survival and prognostic factors in a series of adults with medulloblastomas.
Riffaud L; Saikali S; Leray E; Hamlat A; Haegelen C; Vauleon E; Lesimple T
J Neurosurg; 2009 Sep; 111(3):478-87. PubMed ID: 19231932
[TBL] [Abstract][Full Text] [Related]
6. Medulloblastoma and Collins' law: a critical review of the concept of a period of risk for tumor recurrence and patient survival.
Brown WD; Tavaré CJ; Sobel EL; Gilles FH
Neurosurgery; 1995 Apr; 36(4):691-7. PubMed ID: 7596498
[TBL] [Abstract][Full Text] [Related]
7. Late recurrence of primitive neuroectodermal tumor/medulloblastoma.
Lefkowitz IB; Packer RJ; Ryan SG; Shah N; Alavi J; Rorke LB; Sutton LN; Schut L
Cancer; 1988 Aug; 62(4):826-30. PubMed ID: 2840194
[TBL] [Abstract][Full Text] [Related]
8. Medulloblastoma: freedom from relapse longer than 8 years--a therapeutic cure?
Belza MG; Donaldson SS; Steinberg GK; Cox RS; Cogen PH
J Neurosurg; 1991 Oct; 75(4):575-82. PubMed ID: 1885975
[TBL] [Abstract][Full Text] [Related]
9. Medulloblastoma.
Zhang R; Zhou L
Chin Med J (Engl); 1999 Apr; 112(4):297-301. PubMed ID: 11593525
[TBL] [Abstract][Full Text] [Related]
10. Local control in non-metastatic medulloblastoma.
Christopherson KM; Bradley JA; Rotondo RL; Pincus DW; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
Acta Oncol; 2014 Sep; 53(9):1151-7. PubMed ID: 24991891
[TBL] [Abstract][Full Text] [Related]
11. Medulloblastoma: conventional radiation therapy in comparison to chemo radiation therapy in the post-operative treatment of high-risk patients.
Abd El-Aal HH; Mokhtar MM; Habib E; El-Kashef AT; Fahmy ES
J Egypt Natl Canc Inst; 2005 Dec; 17(4):301-7. PubMed ID: 17102823
[TBL] [Abstract][Full Text] [Related]
12. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
Gajjar A; Chintagumpala M; Ashley D; Kellie S; Kun LE; Merchant TE; Woo S; Wheeler G; Ahern V; Krasin MJ; Fouladi M; Broniscer A; Krance R; Hale GA; Stewart CF; Dauser R; Sanford RA; Fuller C; Lau C; Boyett JM; Wallace D; Gilbertson RJ
Lancet Oncol; 2006 Oct; 7(10):813-20. PubMed ID: 17012043
[TBL] [Abstract][Full Text] [Related]
13. Medulloblastoma: clinical presentation and management. Experience at the hospital for sick children, toronto, 1950-1980.
Park TS; Hoffman HJ; Hendrick EB; Humphreys RP; Becker LE
J Neurosurg; 1983 Apr; 58(4):543-52. PubMed ID: 6827349
[TBL] [Abstract][Full Text] [Related]
14. [Medulloblastoma with neuronal differentiation: a report of five cases].
Nishio S; Morioka T; Inamura T; Takeshita I; Ishihara S; Fukui M
No To Shinkei; 2000 May; 52(5):391-7. PubMed ID: 10845206
[TBL] [Abstract][Full Text] [Related]
15. Population-based study of medulloblastoma: outcomes in Alberta from 1975 to 1996.
Roldán G; Brasher P; Vecil G; Senger D; Rewcastle B; Cairncross G; Forsyth P; Hamilton M
Can J Neurol Sci; 2008 May; 35(2):210-5. PubMed ID: 18574936
[TBL] [Abstract][Full Text] [Related]
16. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment.
Stensvold E; Krossnes BK; Lundar T; Due-Tønnessen BJ; Frič R; Due-Tønnessen P; Bechensteen AG; Myklebust TÅ; Johannesen TB; Brandal P
Acta Oncol; 2017 May; 56(5):698-705. PubMed ID: 28325133
[TBL] [Abstract][Full Text] [Related]
17. Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study.
Hill RM; Richardson S; Schwalbe EC; Hicks D; Lindsey JC; Crosier S; Rafiee G; Grabovska Y; Wharton SB; Jacques TS; Michalski A; Joshi A; Pizer B; Williamson D; Bailey S; Clifford SC
Lancet Child Adolesc Health; 2020 Dec; 4(12):865-874. PubMed ID: 33222802
[TBL] [Abstract][Full Text] [Related]
18. Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea.
Yoon JH; Park KD; Kang HJ; Kim H; Lee JW; Kim SK; Wang KC; Park SH; Kim IH; Shin HY
World J Pediatr; 2017 Aug; 13(4):367-373. PubMed ID: 28550392
[TBL] [Abstract][Full Text] [Related]
19. Recurrence of medulloblastoma 19 years after the initial diagnosis.
Amagasaki K; Yamazaki H; Koizumi H; Hashizume K; Sasaguchi N
Childs Nerv Syst; 1999 Sep; 15(9):482-5. PubMed ID: 10502011
[TBL] [Abstract][Full Text] [Related]
20. Survival results in adult patients treated for medulloblastoma.
Hazuka MB; DeBiose DA; Henderson RH; Kinzie JJ
Cancer; 1992 Apr; 69(8):2143-8. PubMed ID: 1544120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
